The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies. (Q38161944)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24219320%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24219320%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

1 reference

head and neck carcinoma

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24219320%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24219320%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

R Vander Broek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24219320%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Z Chen

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24219320%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C Van Waes

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24219320%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

23 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24219320%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24219320%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24219320%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24219320%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

815-825

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24219320%20AND%20SRC:MED&resulttype=core&format=json

Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1

29 February 2020

cites work

1 reference

Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01.

21 January 2018

1 reference

Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck

21 January 2018

1 reference

A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.

21 January 2018

1 reference

Scaling rules for diffusive drug delivery in tumor and normal tissues

21 January 2018

1 reference

A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region

21 January 2018

1 reference

21 January 2018

The two TORCs and Akt.

1 reference

Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation.

21 January 2018

1 reference

Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression.

21 January 2018

1 reference

Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma.

21 January 2018

1 reference

The PI3K pathway as drug target in human cancer

21 January 2018

1 reference

Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK.

21 January 2018

1 reference

Protein kinase CK2 phosphorylates and upregulates Akt/PKB.

21 January 2018

1 reference

Using structure to define the function of phosphoinositide 3‐kinase family members

21 January 2018

1 reference

Rapamycin inhibits IGF-1-mediated up-regulation of MDM2 and sensitizes cancer cells to chemotherapy

21 January 2018

1 reference

Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma

21 January 2018

1 reference

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

21 January 2018

1 reference

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

21 January 2018

1 reference

Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.

21 January 2018

1 reference

EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy

21 January 2018

1 reference

HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma

21 January 2018

1 reference

PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic

21 January 2018

1 reference

21 January 2018

Phosphoinositide kinases

1 reference

A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer.

21 January 2018

1 reference

A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer

21 January 2018

1 reference

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

21 January 2018

1 reference

eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation

21 January 2018

1 reference

Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration.

21 January 2018

1 reference

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation

21 January 2018

1 reference

The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis

21 January 2018

1 reference

Exploiting the PI3K/AKT pathway for cancer drug discovery

21 January 2018

1 reference

PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer

21 January 2018

1 reference

Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells

21 January 2018

1 reference

A complex interplay between Akt, TSC2 and the two mTOR complexes

21 January 2018

1 reference

Oncogenic PI3K mutations lead to NF-κB-dependent cytokine expression following growth factor deprivation

21 January 2018

1 reference

Exploiting the head and neck cancer oncogenome: widespread PI3K-mTOR pathway alterations and novel molecular targets

21 January 2018

1 reference

Dysregulation of the TSC-mTOR pathway in human disease

21 January 2018

1 reference

Tumours with PI3K activation are resistant to dietary restriction

21 January 2018

1 reference

Epidermal growth factor receptor biology in head and neck cancer

21 January 2018

1 reference

mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin

21 January 2018

1 reference

Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.

21 January 2018

1 reference

Astaxanthin inhibits NF-κB and Wnt/β-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer

21 January 2018

1 reference

A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins

21 January 2018

1 reference

The regulation of cell motility and chemotaxis by phospholipid signaling

21 January 2018

1 reference

The role of PI3K in immune cells

21 January 2018

1 reference

PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma

21 January 2018

1 reference

Loss of PTEN expression as a prognostic marker for tongue cancer

21 January 2018

1 reference

The molecular biology of head and neck cancer

21 January 2018

1 reference

TSC2: filling the GAP in the mTOR signaling pathway

21 January 2018

1 reference

Impact of targeting insulin-like growth factor signaling in head and neck cancers.

21 January 2018

1 reference

Targeting the phosphoinositide 3-kinase pathway in cancer

21 January 2018

1 reference

Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism

21 January 2018

1 reference

Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor

21 January 2018

1 reference

MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers

21 January 2018

1 reference

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

Regulation of cell polarity during epithelial morphogenesis

21 January 2018

1 reference

A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

21 January 2018

1 reference

The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network

21 January 2018

1 reference

Synthesis of the translational apparatus is regulated at the translational level

21 January 2018

1 reference

Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative.

21 January 2018

1 reference

Dysregulated molecular networks in head and neck carcinogenesis

21 January 2018

1 reference

Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers

21 January 2018

1 reference

Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway

21 January 2018

1 reference

High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer

21 January 2018

1 reference

Epidermal growth factor receptor (EGFR) signaling in cancer

21 January 2018

1 reference

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

21 January 2018

1 reference

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

21 January 2018

1 reference

Tuberous sclerosis complex: from Drosophila to human disease.

21 January 2018

1 reference

Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer

21 January 2018

1 reference

Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer.

21 January 2018

1 reference

Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers

21 January 2018

1 reference

PIK3CA mutations in head and neck squamous cell carcinoma

21 January 2018

1 reference

Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model.

21 January 2018

1 reference

Biological significance of c-erbB family oncogenes in head and neck cancer

21 January 2018

1 reference

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

21 January 2018

1 reference

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

Mutant PIK3CA promotes cell growth and invasion of human cancer cells

21 January 2018

1 reference

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

PKB/AKT: functional insights from genetic models

21 January 2018

1 reference

Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression.

21 January 2018

1 reference

Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.

21 January 2018

1 reference

21 January 2018

Cancer statistics, 2013

1 reference

p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas

21 January 2018

1 reference

Immunohistochemical evidence of PTEN in oral squamous cell carcinoma and its correlation with the histological malignancy grading system

21 January 2018

1 reference

PTEN deficiency contributes to the development and progression of head and neck cancer.

21 January 2018

1 reference

The mutational landscape of head and neck squamous cell carcinoma

21 January 2018

1 reference

Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma

21 January 2018

1 reference

Nuclear factor-kappaB in development, prevention, and therapy of cancer

21 January 2018

1 reference

Signalling by PI3K isoforms: insights from gene-targeted mice.

21 January 2018

1 reference

The emerging mechanisms of isoform-specific PI3K signalling

21 January 2018

1 reference

PI3K signalling: the path to discovery and understanding.

21 January 2018

1 reference

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

21 January 2018

Cancer genome landscapes

1 reference

Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma.

21 January 2018

1 reference

PI3K pathway alterations in cancer: variations on a theme

21 January 2018

1 reference

Class 1A PI3K regulates vessel integrity during development and tumorigenesis

21 January 2018

1 reference

Akt activation correlates with adverse outcome in tongue cancer

21 January 2018

1 reference